The ADTRP gene gives instructions for a protein that supports healthy blood vessels and helps regulate the body’s natural clotting signals. If it does not work properly, the balance between vessel health and clot control can be affected. Many variants are harmless, while a few may change how the gene supports artery health. Some studies have linked certain variants in the ADTRP gene with a higher chance of coronary artery disease, but this reflects risk rather than a diagnosis.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, the parts of cells that do the work. Other genes mostly help determine when certain processes happen, where they take place, and how strongly they occur. As a whole, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. More on this topic is available in the LearnHub.
Overview
ADTRPGene function
What if the gene works
The ADTRP gene helps blood vessels develop and supports the lining of blood vessels. It also helps control blood clotting by supporting a natural protein that limits clot formation.
Risk
What if the gene does not work
Changes in the ADTRP gene can reduce tissue factor pathway inhibitor control and disturb signaling that helps blood vessel lining cells stay stable. Milder and more severe variants can differ in how strongly they disrupt these cell processes.
Treatment
What does that mean for your treatment
No ADTRP-specific treatment or drug choice strategy is currently established for people with a pathogenic or loss-of-function variant in the ADTRP gene. The ADTRP gene is being studied for its role in blood vessel lining and clotting-related pathways, but this has not yet changed routine care.
Gene function
What if the gene works
The ADTRP gene helps cells manage certain fats at the cell surface and supports the healthy lining of blood vessels. These routine jobs help keep local cell signals and clotting control more balanced. Understanding ADTRP gene function gives a clearer picture of how blood vessel cells handle daily maintenance.
At the cell surface, the ADTRP gene helps break down a small group of fats called FAHFAs (fat molecules made by linking two fatty acids). This is part of normal lipid turnover and helps cells manage nearby chemical signals.
In blood vessel lining cells, the ADTRP gene helps maintain TFPI, a natural brake on blood clotting. This supports a balanced response so blood can clot when needed while staying under normal control.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene functions more significantly and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
In the ADTRP gene, variants can alter the protein's shape, stability, or the amount made by the cell, which may weaken its activity and its interactions with other cell proteins. Milder variants may leave some function intact, while more severe variants can sharply reduce or abolish protein production. This range helps explain how variants in the ADTRP gene affect protein function at the cellular level.
How variants are linked to conditions
Current research on ADTRP gene variants linked to conditions is still developing. The ADTRP gene does not yet have a broadly confirmed link to a specific health condition, and people with a confirmed ADTRP-related finding should rely on guidance from their doctor or genetic counselor for interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the ADTRP gene. Studies have looked at possible links with blood vessel and heart health, but personal risk still depends on many other genes, age, habits, and overall health.
Inheritance of ADTRP variants
There is not yet a broadly confirmed Mendelian inheritance pattern for ADTRP-related health conditions, so ADTRP gene inheritance is not described in the same clear way as genes tied to well-defined dominant or recessive syndromes. Research is still developing, and different variants in the ADTRP gene may not all have the same clinical meaning. The ADTRP gene is located on chromosome 6, which is an autosome, so you inherit one copy from your mother and one copy from your father.
What does my ADTRP result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for ADTRP, although research on this gene is still developing. If you have a specific ADTRP result, what it means for family members depends on the exact change found and why the test was done.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ADTRP gene variants usually uses a blood or saliva sample. A lab reads the DNA code in the ADTRP gene to look for changes and compares them with known variants. Results may show no variant, a harmless variant, or a variant that needs clinical interpretation.
When should I consider getting a genetic test?
There is not yet a broadly established ADTRP-specific reason to get genetic testing in routine care. Testing decisions are usually based on your personal health, family history, and the reason testing is being considered, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can be informative, but the amount they reveal varies with the condition and the specific variant. Over time, many factors, including age, lifestyle, environment, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes most sense when considered with other parts of care. In other situations, a genetic finding may give a definite answer. For medication response, genetic results can also help frame personal experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medicines. It focuses on the relationship between genes and medications to clarify why the same treatment can work differently from one person to another. For many drugs, genes can influence both how powerfully a medicine works and how the body handles it. This information can support more informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the ADTRP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. Questions about medications, side effects, or your overall health are best discussed with your doctor.
History
In recent decades, awareness of the ADTRP gene’s role has grown. ADTRP entered the medical literature in the early 2010s, when researchers studying blood vessel biology and inherited heart disease risk began to describe it more clearly. Around the same time, large genetic studies linked changes near the ADTRP gene with coronary artery disease, which brought wider attention to it in cardiovascular research. From these first observations, research expanded steadily, and scientists began mapping where the gene sits in the genome and how it relates to nearby risk signals. ADTRP has not become a widely recognized public facing gene in the way some cancer or Alzheimer’s genes have, but it has gained a steady place in modern heart genetics research.